MedTrace Logo

Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

NCT02248207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1293

Last updated 2014-09-25

No results posted yet for this study

Summary

Study to obtain information about the co-operation of the different physician-colleagues in the treatment of patients with Parkinson's disease, both in private practices and clinics and about the primary treatment strategies in the pharmacotherapy of Parkinson's disease and to collect data on the tolerability of Sifrol® in ambulatory patients suffering from Parkinson's disease under routing conditions

Conditions

  • Parkinson Disease

Interventions

DRUG

Pramipexole

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2003-11-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02248207 on ClinicalTrials.gov